Wearable Asthma Monitoring Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Wearable Asthma Monitoring Devices Market is Segmented By Product (Wearable patches, Wearable Wrist Bands, Wearable respiratory monitoring system), By Technology (Cloud-based, AI-based, Other), By End-User (Hospitals, Homecare, Other), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Wearable Asthma Monitoring Devices Market Overview

Wearable asthma monitoring devices market is estimated to reach at a CAGR 24.7% during the forecast period (2023-2030).

Asthma self-monitoring consists of symptom-based and peak expiratory flow (PEF) monitoring. Wearable devices can help with patient monitoring, surveillance, screening, diagnosis, and ongoing management.

Wearable Asthma Monitoring Devices Market Scope

To Know More Insights - Download Sample

Wearable Asthma Monitoring Devices Market Dynamics

The factors influencing the wearable asthma monitoring devices market are the increasing technological advancements, and the increasing prevalence of asthma is expected to drive the market growth.

The increasing technological advancements are expected to drive the market growth in the forecast period

Innovations in personalized health technology offer a once-in-a-lifetime opportunity to create connected healthcare models tailored to the specific needs of patients. Wearable devices can provide crude feedback in the form of reminders to move or stand, prompting users to take more steps per hour or stand more frequently. Some devices, for an additional fee, can provide more detailed personal wellness reports, as well as actionable guidance and coaching to help users achieve their health and fitness goals. On a large scale, wearable devices that generate breathing-related biomedical signals have been developed. Such biomedical signals include breathing sounds and chest movement. Many asthma-related characteristics are included in breathing sound measured by microphones over human skin, such as breathing rate, wheeze, tidal volume, and cough.

Furthermore, signals of chest movement can be obtained using a belt-shaped device or an accelerometer. This signal provides reliable breathing detection because it exhibits simple periodic characteristics and the breathing cycle while remaining unaffected by ambient acoustic noise. For instance, Acoustic monitoring is a type of wearable device that has been researched in asthma. As measured by microphones placed over human skin, breathing sounds can detect breathing patterns (respiratory rate, flow rate, tidal volume) and asthma symptoms (wheeze, cough). Furthermore, chest movement signals can be collected using an accelerometer or a belt-shaped device. Continuous wearable monitoring systems are still a developing field that requires more research into its clinical impact.

The problems associated with wearable monitoring devices is expected to hamper the market growth

Wearable device security and privacy concerns revolve around user data being hacked and manipulated, insecure communication, physical theft of data, use of wearable technology (such as hidden cameras, microphones, and so on) for spying, a lack of encryption, and other vulnerabilities. On occasion, some wearables have been reported to measure data incorrectly. This is particularly dangerous when measuring data such as heart rates. This false reading could lead to overexertion and further health problems in people with heart conditions. With their growing popularity, it's critical to weigh the benefits and drawbacks before committing to one.

Wearable Asthma Monitoring Devices Market COVID-19 Impact Analysis

Pulmonary function testing (PFT) entails a thorough examination of the lungs to provide objective and quantifiable pulmonary function metrics. When a clinician suspects obstructive lung disease, such as chronic obstructive pulmonary disease (COPD) and asthma, or restrictive lung diseases, such as pulmonary fibrosis or sarcoidosis, PFTs are frequently ordered. PFTs are most commonly performed in clinical practice with spirometry and occasionally with lung plethysmography.

However, due to the high risk of COVID-19 transmission during the outpatient testing visit, the American Thoracic Society and many comparable international societies have recommended postponing PFTs during the coronavirus disease 2019 (COVID-19) pandemic. While these restrictions were put in place with expert guidance to prevent disease spread, they have made determining pulmonary function in patients with previously diagnosed lung disease and those recovering from COVID-19 pneumonia who require close follow-up examination difficult. As a result, wearable continuous pulmonary biosensors may play a unique role in assessing pulmonary function without the need for direct inpatient or outpatient examination. Continuous monitoring over time may detect the slow progression of lung disease using non-contact methods, which is especially interesting for specific lung pathologies such as pulmonary fibrosis and COVID-19 acute respiratory distress syndrome (ARDS).

Wearable Asthma Monitoring Devices Market Segment Analysis

The wearable patches segment is expected to dominate the market growth

Smart patches are a type of wearable sensor commonly used in the medical field. They are applied to the patient's skin with an adhesive and have a foam part and embedded electronics to monitor physiological signs such as the patient's pulse. The increasing use of such patches for asthma monitoring is expected to drive market growth. For instance, Sylvee is a new wearable from Respira Labs that continuously measures lung function, ideal for COPD and asthma patients and others who may have temporarily reduced lung function. A particular pandemic that affects lung function comes to mind. Sylvee is a product worn at the lower part of the rib cage and promises to assess lung function easily and continuously without the need to blow into anything. The wearable patch contains speakers and microphones that detect changes in acoustic resonance. According to the company, this is a good proxy for changes in lung air volume, which is the foundation of pulmonary function testing.

Wearable Asthma Monitoring Devices Market Geographical Share

North America region is expected to hold the largest market share in the global wearable asthma monitoring devices market

The increasing technological advancements and increasing prevalence of asthma are expected to drive the market growth in the forecast period.

According to the Asthma and Allergy Foundation of America (AAFA), approximately 25 million Americans have asthma, including 5.1 million children under 18. Healthcare experts believe that asthma is directly related to urbanization because the urban lifestyle exposes people to more air pollution, one of the major causes of high asthma cases in the United States. The presence of key players in this region is expected to drive market growth. For instance, Respira Labs, a company based in the United States, is focused on the progression of, and ultimately preventing, respiratory diseases by providing high-quality, actionable health information to patients, caregivers/families, and clinicians at home. They have developed a patented "acoustic resonance" technology that can detect air trapping, an earlier and more sensitive marker of lung dysfunction, with the support of the NSF and NIH.

Wearable Asthma Monitoring Devices Market Companies and Competitive Landscape

The global wearable asthma monitoring devices market is moderately competitive with mergers, collaborations, and product launches. Some of the key players in the market are Respira Labs, Resmetrix Medical Ltd, Health Care Originals Inc.

Resmetrix Medical Ltd

Overview: Resmetrix is a portfolio company of Israel's MindUP incubator, collaborating with Medtronic, IBM, Pitango, and Rambam Medical Center. Resmetrix has created a one-of-a-kind portable respiratory monitoring system: A wireless chest strap that continuously and accurately monitors, records, and analyses breathing patterns and alerts for early signs of deterioration in a patient's clinical condition. The system serves as a platform for the management of respiratory diseases. The company was founded in 2017.

Product Portfolio: The Resmetrix wearable respiratory monitoring system is a comfortable chest strap that continuously and accurately monitors the patient's respiratory patterns in the hospital, at home, exercising, traveling, or living in a facility. The device wirelessly connects to a smartphone app, which displays real-time respiratory parameters and vital signs and can communicate episodes (exacerbations) early to allow for prompt attention and clinician response.